5 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 5, Unknown 2, Not yet recruiting 1, Recruiting 1 |
Follow Prophylaxis: new trials by email Literature Review of Prophylaxis trials Research Report on Prophylaxis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States Doxycycline, Standard of Care (SOC) - Chlamydia Females, Gonorrhea Female | Phase 4 | Not yet recruiting | Tulane University | 519 | 2027-01-01 | 2026-07-15 |
| Vitamin c Supplementation in the Prevention of CRPS Following Distal Radius Fractures Vitamin C, Placebo - Distal Radius Fracture, Vitamine c | Phase 4 | Completed | Damascus University | 220 | 2023-06-15 | 2026-03-19 |
| Study of Low Molecular Weight Heparins Dalteparin Prefilled Syringe, Tinzaparin profiled syringe - Anticoagulant, Venous Thromboembolism | Phase 4 | Unknown | Herlev Hospital | 65000 | 2023-03-23 | 2023-08-31 |
| Escalating Monthly Doses of Tafenoquine in Healthy Volunteers Tafenoquine prophylaxis - Prophylaxis | Phase 4 | Unknown | Naval Medical Research Center | 200 | 2022-05-10 | 2022-04-11 |
| Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery Apixaban 2.5 milligram - Neoplasms Malignant, Surgery | Phase 4 | Completed | McMaster University | 53 | 2021-02-22 | 2022-04-22 |
| Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts Hydroxychloroquine - Covid19, Hydroxychloroquine | Phase 4 | Completed | Bryn Mawr Hospital | 54 | 2020-05-27 | 2020-12-03 |
| Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants Posaconazole pharmacokinetics - Posaconazole, Pharmacokinetics | Phase 4 | Recruiting | Melbourne Health | 100 | 2019-08-01 | 2025-02-28 |
| Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics Vancomycin Oral - Clostridium Difficile Infection, Prophylaxis | Phase 4 | Completed | St. Luke's Hospital, Chesterfield, Missouri | 51 | 2016-11-01 | 2017-12-27 |
| Cefazolin Pharmacokinetics: Elimination Clearance in Neonates Cefazolin - Prophylaxis | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 40 | 2011-02-01 | 2011-12-13 |
Venous Thromboembolism (2) · COVID-19 (1) · Candidiasis, Invasive (1) · Clostridium Infections (1) · Coronavirus Infections (1) · Invasive Fungal Infections (1) · Malaria (1) · Medication Adherence (1) · Mycoses (1) · Neoplasms (1) · Wrist Fractures (1)
Infections (4) · Bacterial Infections and Mycoses (2) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Thromboembolism (2) · Vascular Diseases (2) · Arm Injuries (1) · Bacterial Infections (1) · Behavior (1) · Candidiasis (1) · Coronaviridae Infections (1) · Fractures, Bone (1) · Gram-Positive Bacterial Infections (1) · Health Behavior (1) · Lung Diseases (1)
Ascorbic Acid (1) · Blood Specimen Collection (1) · Cefazolin (1) · Doxycycline (1) · Hydroxychloroquine (1) · Standard of Care (1) · Vancomycin (1)
Bryn Mawr Hospital (1) · Damascus University (1) · Herlev Hospital (1) · McMaster University (1) · Melbourne Health (1) · Naval Medical Research Center (1) · St. Luke's Hospital, Chesterfield, Missouri (1) · Tulane University (1) · Universitaire Ziekenhuizen KU Leuven (1)
Australia (1) · Canada (1) · Denmark (1) · Syria (1) · United States (1) · Vietnam (1)
Karel Allegaert, MD PhD (1) · Michael D Edstein, PhD (1) · Ryan E Medas, PharmD (1) · Sam Schulman, MD, PhD (1)